Alira Health

Alira Health

Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials

The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants. In addition to questionnaires collected electronically, biometric monitoring technologies such as wearables, are now used by sponsors for drug approval—and require rigorous statistical analysis to generate acceptable clinical evidence.

We are now facing a question: What are the scientific, statistical, and regulatory frameworks for demonstrating the clinical validity of novel digital measures?

Access this Resource on Biometric Monitoring

To explore this question, Adriano Fontanari, Product Marketing at Alira Health, joined Bohdana Ratitch PhD, and her team as a contributor for the article “Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials.”

The paper “Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials” is part of work by the Digital Medicine Society (DiMe) research team, “Standardized statistical approaches to analyze and interpret BioMeTs data,” led by Yasaman Damestani, PhD.

Scientific Articles
Published on:
September 16, 2022
Written by:
Adriano Fontanari
About Alira Health

As experienced consultants, we can help you navigate the complex demands of clinical research, and deploying biometric monitoring solutions. We can provide your company with strategic advice and solutions designed to ensure success across the full product lifecycle.

Related news

Events May 14, 2024
PSI 2024 Conference
Biometrics Biostatistics Data Science
Reports May 7, 2024
Calculator for Simon’s Two-Stage Design and Its Modifications
Our statisticians developed this calculator for a rapid evaluation of the trial. You can get an early futility assessment and modify the design while the trial is still going on. The(...)
Biometrics Biostatistics
Reports July 11, 2023
Five Years Evolution of Chemotherapy Administration in Home Care in France
Have a look at the poster to get an overview of the dynamics in the development of chemotherapy in home care across different French regions during a five-year period.
Clinical France Outcomes Research
Events June 20, 2023
Advanced Wound Care Summit
We are pleased to announce that we will sponsor, attend, and speak at Advanced Wound Care Summit.
Clinical Clinical Trials Wound Healing
Articles June 6, 2023
Content of Integrated Summaries of Efficacy and Safety (ISE/ISS): A Blog Series
Content of Integrated Summaries of Efficacy and Safety (ISE/ISS) blogs outline what elements are required for successful FDA submissions.
Biometrics ISE/ISS
Articles May 30, 2023
Specific Requirements for Integrated Summaries of Efficacy and Safety in FDA Submissions
This article in our Content of Integrated Summaries of Efficacy and Safety series focuses on specific requirements for FDA submissions.
Biometrics ISE/ISS
Articles May 19, 2023
Content of the Integrated Summaries of Efficacy and Safety
This article in our Content of ISE/ISS series focuses on what elements are required in the ISE/ISS to ensure a successful submission.
Biometrics ISE/ISS
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.